How Much Does BPC-157 Cost Per Month From Telehealth Providers?

Telehealth BPC-157 programs typically run $199 to $425 per month. If you want support for workout recovery or a stubborn soft tissue injury without driving to a clinic, Desert Mobile Medical, a Phoenix telemedicine provider, lists $399 per month for the medication plus virtual visits and physician supervision. Your first month often costs more because the intake visit, labs and supplies are added to the medication price.

How much do telehealth programs charge right now?

A September 2026 pricing review from Perfect B, a medical clinic in Doral, Florida, reports online BPC-157 programs at $199 to $425 per month. Those programs prescribe after a brief virtual consult and ship the medication to your home. Perfect B pricing review

Desert Mobile Medical sits near the top of that range. Its product page lists $399 per month and says the fee covers BPC-157 dispensing and dosing, all telemedicine visits and physician supervision with concierge-level support. Desert Mobile Medical BPC-157 page Its shop catalog shows the same $399 plus a processing fee. Desert Mobile Medical peptides catalog

What does that monthly fee actually cover?

The medication itself often costs $150 to $300 per month when a compounding pharmacy mixes it to order. InCare cost guide

First month totals often reach $350 to $495 because clinics add the initial consult, lab work and supplies. InCare cost guide Desert Mobile Medical bundles those pieces. Dispensing, virtual visits and supervision sit inside the one monthly charge.

What should I know before paying for compounded BPC-157?

Telehealth BPC-157 is compounded, which means a state-licensed pharmacy mixes it to order for your prescription. Meto, a telehealth platform, states its compounded medications have not been approved by the FDA and the FDA does not review compounded drugs for safety or efficacy. Meto cost guide

The FDA lists BPC-157 among bulk drug substances nominated for compounding but withdrawn, citing potential significant safety risks. The agency cites possible immune reactions with certain routes, challenges with peptide impurities and ingredient testing, and little or no safety information for the proposed routes. FDA Category 2 safety list Its interim policy says it does not plan enforcement action for Category 1 ingredients under certain conditions, but Category 2 and withdrawn ingredients remain flagged for significant safety concerns. FDA 503A interim policy

Before you pay, ask whether your monthly fee includes medication, follow-up visits, labs, refills and supplies or whether any of those bill separately.